drugset / Trial / NCT01308047
Comparing Heavy Levobupivacaine With Enantiomeric Excess of 50% and Heavy Racemic Bupivacaine.
Phase 3
Withdrawn
Cristália Produtos Químicos Farmacêuticos Ltda.
Irmandade da Santa Casa de Misericordia de Sao Paulo · collabServiço Social da Indústria do Papel, Papelão e Cortiça do Estado de São Paulo · collab
RandomizedParallel-groupTriple-blindSupportive care
Summary
The purpose of this study is to compare the non-inferiority between Heavy Levobupivacaine with Enantiomeric Excess of 50% and Heavy Racemic Bupivacaine During Spinal Anesthesia for Orthopedic Procedures in the Lower Limbs.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Outcome
Outcome not reported
Stopped: “The Sponsor has no interest in continuing the study.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 15 mg | Other |
Indications
No indication recorded.